Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Biden transition and vaccine hopes drive up stocks, oil and bitcoin

Tue, 24th Nov 2020 12:35

* Risk currencies gain as uncertainty retreats

* Vaccine could be released by mid-December

* Trump, government officials nod to formal Biden transition

* Bitcoin hits 19,000

* For a Reuters live blog on U.S., UK and European stock
markets,
click LIVE/ or type LIVE/ in a news window.

By Lawrence White and Julie Zhu

LONDON/HONG KONG, Nov 24 (Reuters) - Stocks, oil and risk
currencies, including bitcoin, gained on Tuesday as U.S.
President-elect Joe Biden got the formal go-ahead to begin his
transition to the White House.

The world's most popular cryptocurrency rose 3%
to near its record high, leading a surge in risk appetite as the
European STOXX 600 index climbed 0.6% and Brent
crude rose to its highest level since March at $46.52 a
barrel. Safe-haven assets such as gold fell.

After weeks of legal challenges to the election results,
U.S. General Services Administration chief Emily Murphy wrote to
Biden on Monday informing him the formal handover process could
begin.

President Donald Trump tweeted that he had told his team "do
what needs to be done with regard to initial protocols", an
indication he was moving towards a transition.

"Markets have been constrained by very high levels of
uncertainty on the U.S. political front and around vaccines for
weeks, so with those two going away investors are considering
the prospect of a return to normality in 2021," said Emmanuel
Cau, head of European equity strategy at Barclays.

Reports that Biden plans to nominate former Federal Reserve
Chair Janet Yellen to become the next Treasury Secretary further
boosted U.S. stocks on expectations she would pursue more
conventional policies than the departing Steven Mnuchin.

Futures for the S&P 500 rose 0.8% in European
trading hours, putting the 49-country MSCI world stocks index on
course to set a record high later.

Later on Tuesday, Biden and Vice President-elect Kamala
Harris are expected to formally introduce their appointments to
critical national security and foreign policy positions in
Wilmington, Delaware.

Japan's Nikkei jumped 2.5% to its highest level
since May 1991 overnight, with energy, real estate and financial
shares leading the advance.

Asia-Pacific shares outside Japan had ticked
up 0.4%. Australia's S&P/ASX 200 was 1.26% stronger,
touching its highest level in almost nine months, with energy
stocks leading the pack there.

Chinese blue chips were an outlier among positive
Asian shares, edging down 0.6%, as investors booked profits
following recent strong gains.

RISK ON

AstraZeneca and Oxford University said on Monday
that their COVID-19 vaccine, which is cheaper to make, easier to
distribute and faster to scale up than its rivals, could be as
much as 90% effective.

The progress made on COVID-19 vaccines helped drive risk
appetite, as investors looked past short-term economic pain from
the pandemic to a brighter 2021.

The South African rand and the Russian rouble
extended this week's winning run. MSCI's index of emerging
markets equities held the 32-month high reached in the
previous session.

The New Zealand dollar was also among the currency
gainers, rising as much as 0.9% to a two-year high of $0.6986 as
its central bank said house prices, which have been climbing
higher this year, could be included in its inflation basket.

The euro was gaining towards $1.19 again and the
dollar index, which tracks the dollar against a basket of
six major currencies, nudged down to 92.242.

Bitcoin broke past $19,000 for the first time in
nearly three years, as demand for assets perceived as resistant
to inflation grows.

Also spurred on by the vaccine hopes, oil reached levels not
seen since before the coronavirus pandemic began to spread in
March.

Brent crude futures rose 39 cents, or 0.9%, to
$46.45 a barrel to add to a more than 20% surge this month. U.S.
West Texas Intermediate crude added 46 cents, or 1.1%, to
$43.52.

"Progress on developing and distributing a vaccine de-risks
the path back to normal for oil markets," said Stephen Innes,
chief global markets strategist at financial services firm Axi.

SHORT-TERM PAIN

Amid the gains on Tuesday, however, were some reminders of
how the COVID-19 pandemic is inflicting economic pain. Germany's
gross domestic product grew by a record 8.5% in the third
quarter, but the Ifo institute's survey of business morale
pointed to fears of a recession to come as the index fell to
90.7 from a downwardly revised 92.5 in October.

The Turkish lira fell almost 1.5% to trade at 7.9899
per dollar, its weakest since Nov. 11, as new coronavirus
restrictions began and investors look for signs of sustained
central bank support.

In the bond markets, the yield on the U.S. benchmark 10-year
notes rose slightly to 0.87% as did those on most
European government bonds. Germany's 10-year yield was up 1
basis point to -0.58% in morning trade.

Gold fell 1% to $1,814 an ounce, having dropped 10%
this month.

(Reporting by Lawrence White, Julie Zhu and Katanga Johnson;
editing by Shri Navaratnam, Philippa Fletcher, Nick Macfie,
Larry King
For Reuters Live Markets blog on European and UK stock markets,
please click on:)

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.